Archive

Could new gene-editing technique reverse vision loss?

Written by Gary Finnegan | 12 Apr 2023

The potential of gene-editing technology to prevent and treat illness has attracted enormous attention over the past decade. At the heart this new wave of research is CRISPR,… read more.

“Step therapy” effective for diabetic macular edema

Written by Bruce Sylvester | 28 Jul 2022

Researchers report that a therapeutic “step strategy,” in which patients with diabetic macular edema begin their treatment with a less expensive drug and, if vision fails to improve,… read more.

New two-year data for Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two causes of vision loss – Genentech/Roche

Written by Charlie King | 9 Apr 2022

Genentech, announced that new two-year data from its Phase III studies of Vabysmo (faricimab-svoa) and Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant will be… read more.

Cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Written by Charlie King | 28 Jan 2022

Inhibiting ceramide accumulation in retina protects photoreceptors, improves vision. Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one… read more.

Archive

Could new gene-editing technique reverse vision loss?

“Step therapy” effective for diabetic macular edema

New two-year data for Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two causes of vision loss – Genentech/Roche

Cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Subscribe for our mailing list

Follow Us